Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Anticancer Research
|
April 1, 2009
Novel regimens of capecitabine alone and combined with irinotecan and bevacizumab in colorectal cancer xenografts
Kenneth Kolinsky, Yu-E Zhang, Ute Dugan, et al.
Breast Disease
|
June 4, 2010
Optimizing chemotherapy dose and schedule by Norton-Simon mathematical modeling
Tiffany A Traina, Ute Dugan, Brian Higgins, et al.
Anticancer Research
|
August 19, 2007
Antitumor activity of capecitabine and bevacizumab combination in a human estrogen receptor-negative breast adenocarcinoma xenograft model
Brian Higgins, Kenneth Kolinsky, Michael Linn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2008
Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancer
Tiffany A Traina, Maria Theodoulou, Kimberly Feigin, et al.
Molecular Cancer Therapeutics
|
January 14, 2009
In vivo activity of novel capecitabine regimens alone and with bevacizumab and oxaliplatin in colorectal cancer xenograft models
Kenneth Kolinsky, Ben-Quan Shen, Yu-E Zhang, et al.
JCO Global Oncology
|
June 8, 2023
Analysis of Cancer Research Projects in Sub-Saharan Africa: A Quantitative Perspective on Unmet Needs and Opportunities
Lynne Davies, Danny A Milner, Lawrence N Shulman, et al.
JCO Global Oncology
|
January 25, 2021
Multisector Collaborations and Global Oncology: The Only Way Forward
Charmaine Blanchard, Buhle Lubuzo, Frederick Chite Asirwa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 18, 2025
Clinical and Translational Results from PORTER, a Multicohort Phase I Platform Trial of Combination Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
Matthew D Galsky, Karen A Autio, Christopher R Cabanski, et al.
Journal for Immunotherapy of Cancer
|
January 30, 2026
Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma
Eileen M O'Reilly, Christopher R Cabanski, Jaclyn P Lyman, et al.
The Lancet. Oncology
|
January 2, 2021
CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study
Mark H O'Hara, Eileen M O'Reilly, Gauri Varadhachary, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Anticancer Research
|
April 1, 2009
Novel regimens of capecitabine alone and combined with irinotecan and bevacizumab in colorectal cancer xenografts
Kenneth Kolinsky, Yu-E Zhang, Ute Dugan, et al.
Breast Disease
|
June 4, 2010
Optimizing chemotherapy dose and schedule by Norton-Simon mathematical modeling
Tiffany A Traina, Ute Dugan, Brian Higgins, et al.
Anticancer Research
|
August 19, 2007
Antitumor activity of capecitabine and bevacizumab combination in a human estrogen receptor-negative breast adenocarcinoma xenograft model
Brian Higgins, Kenneth Kolinsky, Michael Linn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2008
Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancer
Tiffany A Traina, Maria Theodoulou, Kimberly Feigin, et al.
Molecular Cancer Therapeutics
|
January 14, 2009
In vivo activity of novel capecitabine regimens alone and with bevacizumab and oxaliplatin in colorectal cancer xenograft models
Kenneth Kolinsky, Ben-Quan Shen, Yu-E Zhang, et al.
JCO Global Oncology
|
June 8, 2023
Analysis of Cancer Research Projects in Sub-Saharan Africa: A Quantitative Perspective on Unmet Needs and Opportunities
Lynne Davies, Danny A Milner, Lawrence N Shulman, et al.
JCO Global Oncology
|
January 25, 2021
Multisector Collaborations and Global Oncology: The Only Way Forward
Charmaine Blanchard, Buhle Lubuzo, Frederick Chite Asirwa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 18, 2025
Clinical and Translational Results from PORTER, a Multicohort Phase I Platform Trial of Combination Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
Matthew D Galsky, Karen A Autio, Christopher R Cabanski, et al.
Journal for Immunotherapy of Cancer
|
January 30, 2026
Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma
Eileen M O'Reilly, Christopher R Cabanski, Jaclyn P Lyman, et al.
The Lancet. Oncology
|
January 2, 2021
CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study
Mark H O'Hara, Eileen M O'Reilly, Gauri Varadhachary, et al.
Page
of 2